Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 13, 2017 - Issue 3
Submit an article Journal homepage
213
Views
10
CrossRef citations to date
0
Altmetric
Perspective

C1858T Polymorphism of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22): an eligible target for prevention of type 1 diabetes?

Giovanni PreziosoDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyCorrespondence[email protected]
View further author information
,
Laura ComegnaDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyView further author information
,
Concetta Di GiulioDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyView further author information
,
Simone FranchiniDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyView further author information
,
Francesco ChiarelliDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyView further author information
&
Annalisa BlasettiDepartment of Pediatrics, ‘G. D’Annunzio’ University, Chieti, ItalyView further author information
Pages 189-196 | Received 21 May 2016, Accepted 25 Nov 2016, Published online: 08 Dec 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Khaled A. Alswat, Amre Nasr, Mohammed S. Al Dubayee, Iman M. Talaat, Adnan A. Alsulaimani, Imad A.A. Mohamed & Gamal Allam. (2018) The Potential Role of PTPN-22 C1858T Gene Polymorphism in the Pathogenesis of Type 1 Diabetes in Saudi Population. Immunological Investigations 47:5, pages 521-533.
Read now

Articles from other publishers (9)

Sana Rafaqat, Jaida Manzoor, Rimsha Akhter, Zain Ishaque, Asifa Kamal, Faiza Saleem & Rasheeda Bashir. (2023) Genetic association of PTPN22 polymorphisms with Type 1 diabetes in Pakistani children. Journal of King Saud University - Science 35:10, pages 102967.
Crossref
Hermann AM Mucke. (2022) Patent highlights October–November 2021. Pharmaceutical Patent Analyst 11:2, pages 37-44.
Crossref
Ghaleb Bin Huraib, Fahad Al Harthi, Misbahul Arfin & Abdulrahman Al-Asmari. 2020. The Recent Topics in Genetic Polymorphisms. The Recent Topics in Genetic Polymorphisms.
Liyan Li, Shudong Liu & Junxia Yu. (2020) Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201882095832.
Crossref
Anna U Kraus, Marissa Penna-Martinez, Firouzeh Shoghi, Christian Seidl, Gesine Meyer & Klaus Badenhoop. (2019) HLA-DQB1 Position 57 Defines Susceptibility to Isolated and Polyglandular Autoimmunity in Adults: Interaction With Gender. The Journal of Clinical Endocrinology & Metabolism 104:6, pages 1907-1916.
Crossref
C. Giorgio, M. Incerti, D. Pala, S. Russo, P. Chiodelli, M. Rusnati, A.M. Cantoni, R. Di Lecce, E. Barocelli, S. Bertoni, P. Ravassard, F. Manenti, L. Piemonti, F. Ferlenghi, A. Lodola & M. Tognolini. (2019) Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice. Pharmacological Research 141, pages 319-330.
Crossref
María Elena Soto, Isela Montufar-Robles, Silvia Jiménez-Morales, Ricardo Gamboa, Claudia Huesca-Gómez & Julian Ramírez-Bello. (2018) An association study in PTPN22 suggests that is a risk factor to Takayasu’s arteritis. Inflammation Research 68:3, pages 195-201.
Crossref
Varun Pathak, Nupur Madhur Pathak, Christina L O’Neill, Jasenka Guduric-Fuchs & Reinhold J Medina. (2019) Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives. Clinical Medicine Insights: Endocrinology and Diabetes 12, pages 117955141984452.
Crossref
Mohammad Z. Haider, Majedah A. Rasoul, Maria Al-Mahdi, Hessa Al-Kandari & Gursev S. Dhaunsi. (2018) Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs. PLOS ONE 13:6, pages e0198652.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.